Quadrant Capital Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-377
| Closed | -$8.91K | – | 2795 |
|
|
2023
Q4 | $8.91K | Hold |
377
| – | – | ﹤0.01% | 2108 |
|
|
2023
Q3 | $5.62K | Buy |
377
+141
| +60% | +$2.1K | ﹤0.01% | 2143 |
|
|
2023
Q2 | $2.59K | Hold |
236
| – | – | ﹤0.01% | 2364 |
|
|
2023
Q1 | $2.06K | Hold |
236
| – | – | ﹤0.01% | 2425 |
|
|
2022
Q4 | $1.48K | Hold |
236
| – | – | ﹤0.01% | 2475 |
|
|
2022
Q3 | $1K | Hold |
236
| – | – | ﹤0.01% | 2598 |
|
|
2022
Q2 | $1K | Sell |
236
-199
| -46% | -$843 | ﹤0.01% | 2489 |
|
|
2022
Q1 | $1K | Buy |
+435
| New | +$1K | ﹤0.01% | 2440 |
|
|
2021
Q3 | – | Sell |
-107
| Closed | – | – | 2697 |
|
|
2021
Q2 | $0 | Buy |
+107
| New | – | ﹤0.01% | 2611 |
|